SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 30 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | 0.0% | 22,035 | -0.7% | 0.00% | – |
| Q1 2022 | $5,000 | 0.0% | 22,184 | +16.7% | 0.00% | – |
| Q4 2021 | $5,000 | -44.4% | 19,016 | -3.0% | 0.00% | – |
| Q3 2021 | $9,000 | -25.0% | 19,608 | -4.8% | 0.00% | – |
| Q2 2021 | $12,000 | -14.3% | 20,598 | -1.2% | 0.00% | – |
| Q1 2021 | $14,000 | +600.0% | 20,854 | +266.0% | 0.00% | – |
| Q1 2020 | $2,000 | +100.0% | 5,698 | +100.3% | 0.00% | – |
| Q3 2019 | $1,000 | – | 2,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 960,680 | $655,000 | 0.02% |
| Virtu Financial LLC | 466,704 | $318,000 | 0.02% |
| tru Independence LLC | 60,000 | $30,000 | 0.01% |
| Jacobi Capital Management LLC | 18,500 | $13,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 109,300 | $75,000 | 0.00% |
| Focused Wealth Management, Inc | 500 | $0 | 0.00% |
| UBS Group AG | 576,927 | $393,000 | 0.00% |
| Stratos Wealth Partners, LTD. | 10,850 | $7,000 | 0.00% |
| NewEdge Advisors, LLC | 14,187 | $10,000 | 0.00% |
| Sowell Financial Services LLC | 74 | $0 | 0.00% |